Company / PP&E per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$3.65
FY2025
5-year range
$3.65 / $5.48
FY2021-FY2025
Trend
-11.7%
vs FY2024
Sector context
#21 of 191
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's pp&e per share of $3.65 is higher than 89% of companies in the Health Care sector (FY2025). PP&E per Share has declined for 7 consecutive years, from $7146722.16 in FY2018 to $3.65 in FY2025.
Based on SEC 10-K filings.
3.65 in FY2025 with a 5-year CAGR of -10.0%. Top quartile in the Health Care sector.
Declined from $5.19 to $3.65 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -11.4%
- 5-Year CAGR
- -10.0%
- 10-Year CAGR
- -
Sector benchmark
-80.7% below sector average
Key checks
Key Insights
- TEVA PHARMACEUTICAL INDUSTRIES LTD's pp&e per share has declined for 7 consecutive years.
- In FY2025, pp&e per share decreased 11.7% year-over-year.
- Ranks #21 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.65 | -11.7% |
| FY2024 | $4.13 | -20.5% |
| FY2023 | $5.19 | -0.9% |
| FY2022 | $5.24 | -4.4% |
| FY2021 | $5.48 | -11.1% |
| FY2020 | $6.17 | -2.7% |
| FY2019 | $6.33 | -100.0% |
| FY2018 | $7146722.16 | +94631331.2% |
| FY2017 | $7.55 | -100.0% |
| FY2016 | $8400624.35 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026